Global Amblyopia Clinical Trials Review, H2, 2018 Featuring Herantis Pharma & Santen Pharmaceutical - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Amblyopia Global Clinical Trials Review, H2, 2018" clinical trials has been added to ResearchAndMarkets.com's offering.

Amblyopia Global Clinical Trials Review, H2, 2018" provides an overview of Amblyopia clinical trials scenario. This report provides top line data relating to the clinical trials on Amblyopia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). These reports are generated using a proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Reasons to Buy

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional and country level

Key Topics Covered:

1. Report Guidance
2. Clinical Trials Report Coverage
3. Clinical Trials by Region
4. Clinical Trials and Average Enrollment by Country
5. Top Countries Contributing to Clinical Trials in Asia-Pacific
6. Top Countries Contributing to Clinical Trials in Europe
7. Top Countries Contributing to Clinical Trials in North America
8. Top Countries Contributing to Clinical Trials in Middle East and Africa
9. Clinical Trials by G7 Countries: Proportion of Amblyopia to Ophthalmology Clinical Trials
10. Clinical Trials by Phase in G7 Countries
11. Clinical Trials in G7 Countries by Trial Status
12. Clinical Trials by E7 Countries: Proportion of Amblyopia to Ophthalmology Clinical Trials
13. Clinical Trials by Phase in E7 Countries
14. Clinical Trials in E7 Countries by Trial Status
15. Clinical Trials by Phase
16. In Progress Trials by Phase
17. Clinical Trials by Trial Status
18. Clinical Trials by End Point Status
19. Subjects Recruited Over a Period of Time
20. Clinical Trials by Sponsor Type
21. Prominent Sponsors
22. Top Companies Participating in Amblyopia Therapeutics Clinical Trials
23. Prominent Drugs
24. Clinical Trial Profile Snapshots
25. Appendix
    

Companies Mentioned

• Herantis Pharma Plc
• Santen Pharmaceutical Co Ltd

For more information about this clinical trials report visit https://www.researchandmarkets.com/research/2d325w/global_amblyopia?w=4